HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Aminoglycoside-resistant Aeromonas hydrophila as part of a polymicrobial infection following a traumatic fall into freshwater.

Abstract
Amikacin is a first-line treatment for Aeromonas infection due to high efficacy. There are few reports of aminoglycoside-resistant Aeromonas spp. We report a soft tissue infection containing multiple pathogens, including a strain of Aeromonas hydrophila resistant to amikacin, tobramycin, and multiple cephalosporins.
AuthorsJoshua R Shak, Jennifer A Whitaker, Bruce S Ribner, Eileen M Burd
JournalJournal of clinical microbiology (J Clin Microbiol) Vol. 49 Issue 3 Pg. 1169-70 (Mar 2011) ISSN: 1098-660X [Electronic] United States
PMID21209173 (Publication Type: Case Reports, Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Aminoglycosides
  • Anti-Bacterial Agents
  • Cephalosporins
  • Amikacin
  • Tobramycin
Topics
  • Adult
  • Aeromonas hydrophila (drug effects, isolation & purification)
  • Amikacin (pharmacology)
  • Aminoglycosides (pharmacology)
  • Anti-Bacterial Agents (pharmacology)
  • Bacterial Infections (diagnosis, microbiology)
  • Cephalosporins (pharmacology)
  • Drug Resistance, Bacterial
  • Fresh Water
  • Humans
  • Male
  • Microbial Sensitivity Tests
  • Soft Tissue Infections (diagnosis, microbiology)
  • Tobramycin (pharmacology)
  • Wounds and Injuries (complications)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: